Favorable and adverse effects of chronic hydroxyurea (HU) therapy for adults with sickle cell anemia with high disease severity.37,38
Decreased pain events
Decreased acute chest syndrome
Decreased need for transfusion
Decreased mortality
Decreased hemolysis
Transient decreases in blood counts
? unknown long-term exposure risk
? teratogenic effects
Sign In or Create an Account